APA (7th ed.) Citation

Pelemans, H., Esnouf, R., Dunkler, A., Parniak, M., Vandamme, A., Karlsson, A., . . . Balzarini, J. (1997). Characteristics of the Pro225His mutation in human immunodeficiency virus type 1 (HIV-1) reverse transcriptase that appears under selective pressure of dose-escalating quinoxaline treatment of HIV-1.

Chicago Style (17th ed.) Citation

Pelemans, H., R. Esnouf, A. Dunkler, M. Parniak, A. Vandamme, A. Karlsson, E. De Clercq, J. Kleim, and J. Balzarini. Characteristics of the Pro225His Mutation in Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcriptase That Appears Under Selective Pressure of Dose-escalating Quinoxaline Treatment of HIV-1. 1997.

MLA (9th ed.) Citation

Pelemans, H., et al. Characteristics of the Pro225His Mutation in Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcriptase That Appears Under Selective Pressure of Dose-escalating Quinoxaline Treatment of HIV-1. 1997.